版本:
中国

BRIEF-Philips receives FDA clearance to market pathology solution in the U.S.

April 13 Koninklijke Philips NV:

* Receives clearance from the U.S. Food and Drug Administration (FDA) to market Philips Intellisite pathology solution for primary diagnostic use in the U.S. Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐